News J&J looks to Actelion to boost sales after poor Q1 Johnson & Johnson is hoping its new acquisition Actelion will help stave off the effects of a price squeeze in the US, and a cheaper biosimilar of its bestseller, Remicade.
News UK court overturns AbbVie Humira patents Decision paves way for cheaper competitor in autumn 2018.
News Lilly’s RA drug Olumiant gains first approval in Europe Oral treatment could take the lead among next generation RA drugs
News Sanofi's Kevzara gains first approval in Canada Sanofi and Regeneron's new rheumatoid arthritis (RA) drug Kevzara has gained its first global approval in Canada.
News Delinia adds to Celgene's immunology ambitions Celgene continues with focus on autoimmune diseases.
News European Commission approves 2nd IPCEI to sum of €403m The European Commission has approved, under EU State aid rules, the second health-related IPCEI to support innovations in medical devices.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face